Gel to help heal skin wounds after removing benign moles
Part of Injuries & trauma, Skin clinical trials.
This trial tests a gel called LUT017 to see if it improves how skin wounds heal after removing benign skin lesions like moles or seborrheic keratoses. If you are a healthy adult having at least two such lesions removed, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having at least two benign skin lesions (like moles or age spots) removed, creating comparable wounds for treatment.
- You are 18 years or older.
- You are generally healthy, with no condition that might slow down normal wound healing.
- The lesions to be removed have been confirmed as benign by your dermatologist or surgeon.
- You can provide informed consent and follow the study procedures.
- If you are a woman who could become pregnant, you must have a negative pregnancy test at the start and use highly effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a gel applied on hard-to-heal leg ulcers to see if it can help them heal. It is for people with chronic venous leg ulcers that have not healed for at least 4 weeks but less than 2 years.
This trial tests a topical gel (a cream you apply to skin) containing sirolimus to treat angiokeratomas, which are small growths on the skin. The goal is to see if this treatment is safe and effective.
This trial tests a drug called Verteporfin, applied to surgical wounds after removing a skin lesion (like a mole) to see if it helps healing and prevents scarring. It's for people who need a small second surgery to make sure all abnormal cells are gone.
This study tests a device that uses a special light to image skin lesions after applying an FDA-approved cream. It aims to see if the device can help doctors see benign skin growths more clearly before they are removed.
This trial tests an investigational gel called HW211026 for people with actinic keratosis, a common precancerous skin condition. It aims to see if the gel is a safe and effective treatment for lesions on the face.
This study tests an experimental drug called FLD-103 injected into a specific type of skin cancer (nodular basal cell carcinoma) that hasn't been treated before. The goal is to see if it helps remove the cancer before final surgery.
Hear when a new Wound Healing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.